Eugene Shenderov

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 12

Top Topics

Squamous Cell Carcinoma

Radical Prostatectomy

Top Venues

Cancer research communications

JCO precision oncology

Nature medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Carly D Miller, John R Lozada, Nicholas A Zorko, Andrew Elliott, Allison Makovec, Milan Radovich, Elisabeth I Heath, Archana M Agarwal, Rana R McKay, Rohan Garje, Bruno R Bastos, Dave S B Hoon, Jacob J Orme, A Oliver Sartor, Ari M VanderWalde, Chadi Nabhan, George W Sledge, Eugene Shenderov, Scott M Dehm, Emil Lou, Jeffrey S Miller, Justin H Hwang, Emmanuel S Antonarakis
Pan-Cancer Interrogation of B7-H3 (CD276) as an Actionable Therapeutic Target Across Human Malignancies. Cancer research communications 4 (5) (2024)
Carly D Miller, John R Lozada, Nicholas A Zorko, Andrew Elliott, Allison Makovec, Milan Radovich, Elisabeth I Heath, Archana M Agarwal, Rana R McKay, Rohan Garje, Bruno R Bastos, Dave S B Hoon, Jacob J Orme, A Oliver Sartor, Ari M VanderWalde, Chadi Nabhan, George W Sledge, Eugene Shenderov, Scott M Dehm, Emil Lou, Jeffrey S Miller, Justin H Hwang, Emmanuel S Antonarakis
Pan-Cancer Interrogation of B7-H3 (CD276) as an Actionable Therapeutic Target across Human Malignancies. Cancer research communications (2024)
Carly D Miller, John R Lozada, Nicholas A Zorko, Andrew Elliott, Allison Makovec, Milan Radovich, Elisabeth I Heath, Archana M Agarwal, Rana R McKay, Rohan Garje, Bruno R Bastos, Dave S B Hoon, Jacob J Orme, A Oliver Sartor, Ari M VanderWalde, Chadi Nabhan, George W Sledge, Eugene Shenderov, Scott M Dehm, Emil Lou, Jeffrey S Miller, Justin H Hwang, Emmanuel S Antonarakis
Pan-Cancer Interrogation of B7-H3 (CD276) as an Actionable Therapeutic Target Across Human Malignancies. Cancer research communications 4 (5) (2024)
Sanaz Nourmohammadi Abadchi, Laura A Sena, Emmanuel S Antonarakis, Colin C Pritchard, James R Eshleman, Eric Quentin Konnick, Stephen J Salipante, Eugene Shenderov, Tamara L Lotan
MLH1 Loss in Primary Prostate Cancer. JCO precision oncology 7 (2023)
Eugene Shenderov, Angelo M DeMarzo, Tamara L Lotan, Hao Wang, Sin Chan, Su Jin Lim, Hongkai Ji, Mohamad E Allaf, Carolyn Chapman, Paul A Moore, Francine Chen, Kristina Sorg, Andrew M White, Sarah E Church, Briana Hudson, Paul A Fields, Shaohui Hu, Samuel R Denmeade, Kenneth J Pienta, Christian P Pavlovich, Ashley E Ross, Charles G Drake, Drew M Pardoll, Emmanuel S Antonarakis
Neoadjuvant enoblituzumab in localized prostate cancer: a single-arm, phase 2 trial. Nature medicine (2023)
Adrianna A Mendes, Jiayun Lu, Harsimar B Kaur, Siqun L Zheng, Jianfeng Xu, Jessica Hicks, Adam B Weiner, Edward M Schaeffer, Ashley E Ross, Steven P Balk, Mary-Ellen Taplin, Nathan A Lack, Emirhan Tekoglu, Janielle P Maynard, Angelo M De Marzo, Emmanuel S Antonarakis, Karen S Sfanos, Corinne E Joshu, Eugene Shenderov, Tamara L Lotan
Association of B7-H3 expression with racial ancestry, immune cell density, and androgen receptor activation in prostate cancer. Cancer 128 (12) (2022)
John-William Sidhom, Ingharan J Siddarthan, Bo-Shiun Lai, Adam Luo, Bryan C Hambley, Jennifer Bynum, Amy S Duffield, Michael B Streiff, Alison R Moliterno, Philip Imus, Christian B Gocke, Lukasz P Gondek, Amy E DeZern, Alexander S Baras, Thomas Kickler, Mark J Levis, Eugene Shenderov
Deep learning for diagnosis of acute promyelocytic leukemia via recognition of genomically imprinted morphologic features. NPJ precision oncology 5 (1) (2021)
Eugene Shenderov, Matheswaran Kandasamy, Uzi Gileadi, Jili Chen, Dawn Shepherd, James Gibbs, Gennaro Prota, Jonathan D Silk, Jonathan W Yewdell, Vincenzo Cerundolo
Generation and characterization of HLA-A2 transgenic mice expressing the human TCR 1G4 specific for the HLA-A2 restricted NY-ESO-1157-165 tumor-specific peptide. Journal for immunotherapy of cancer 9 (6) (2021)
Eugene Shenderov, Karim Boudadi, Wei Fu, Hao Wang, Rana Sullivan, Alice Jordan, Donna Dowling, Rana Harb, Joseph Schonhoft, Adam Jendrisak, Michael A Carducci, Mario A Eisenberger, James R Eshleman, Jun Luo, Charles G Drake, Drew M Pardoll, Emmanuel S Antonarakis
Nivolumab plus ipilimumab, with or without enzalutamide, in AR-V7-expressing metastatic castration-resistant prostate cancer: A phase-2 nonrandomized clinical trial. The Prostate 81 (6) (2021)
Mark C Markowski, Eugene Shenderov, Mario A Eisenberger, Sushant Kachhap, Drew M Pardoll, Samuel R Denmeade, Emmanuel S Antonarakis
Extreme responses to immune checkpoint blockade following bipolar androgen therapy and enzalutamide in patients with metastatic castration resistant prostate cancer. The Prostate 80 (5) (2020)
Eugene Shenderov, Emmanuel S Antonarakis
Reimagining Vaccines for Prostate Cancer: Back to the Future. Clinical cancer research : an official journal of the American Association for Cancer Research 26 (19) (2020)
Eugene Shenderov, Pedro Isaacsson Velho, Anas H Awan, Hao Wang, Nooshin Mirkheshti, Tamara L Lotan, Michael A Carducci, Drew M Pardoll, Mario A Eisenberger, Emmanuel S Antonarakis
Genomic and clinical characterization of pulmonary-only metastatic prostate cancer: A unique molecular subtype. The Prostate 79 (13) (2019)